Susquehanna International Group’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-235
Closed -$12K 14282
2022
Q2
$12K Sell
235
-74
-24% -$4.44K ﹤0.01% 12482
2022
Q1
$17K Sell
309
-534
-63% -$32.3K ﹤0.01% 12672
2021
Q4
$56K Sell
843
-734
-47% -$63.7K ﹤0.01% 12492
2021
Q3
$162K Sell
1,577
-232
-13% -$24.8K ﹤0.01% 11730
2021
Q2
$206K Sell
1,809
-2,059
-53% -$239K ﹤0.01% 11544
2021
Q1
$480K Buy
3,868
+3,548
+1,109% +$496K ﹤0.01% 9575
2020
Q4
$33K Buy
320
+102
+47% +$12K ﹤0.01% 10831
2020
Q3
$36K Buy
+218
New +$45.3K ﹤0.01% 10288

Other funds holding QNTM

Susquehanna International Group's QNTM Position: Q3 2024 in Review

Susquehanna International Group sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q3 2024, closing a stake of 430 shares — an estimated $4.47K sold.

Susquehanna International Group first reported a position in QNTM in Q3 2020 and held it in 16 quarters. The position peaked at $578K in Q1 2021. 12 funds tracked by Wall St. Rank hold QNTM as of Q3 2024.

  • Susquehanna International Group reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q3 2024 after selling out during the quarter.
  • Susquehanna International Group sold 430 Quantum Biopharma Class B Subordinate Voting Shares shares in Q3 2024, an estimated $4.47K.
  • Susquehanna International Group first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q3 2020 and held it in 16 quarters.
  • Susquehanna International Group's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $578K in Q1 2021.
  • 12 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.